Skip to main content
Erschienen in: Diabetologia 4/2018

09.12.2017 | Article

Acute loss of adipose tissue-derived adiponectin triggers immediate metabolic deterioration in mice

verfasst von: Jonathan Y. Xia, Kai Sun, Chelsea Hepler, Alexandra L. Ghaben, Rana K. Gupta, Yu A. An, William L. Holland, Thomas S. Morley, Andrew C. Adams, Ruth Gordillo, Christine M. Kusminski, Philipp E. Scherer

Erschienen in: Diabetologia | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Aim/hypothesis

Adiponectin (APN), a circulating hormone secreted by mature adipocytes, has been extensively studied because it has beneficial metabolic effects. While many studies have focused on the congenital loss of APN and its effects on systemic body glucose and lipid metabolism, little is known about the effects triggered by acute loss of APN in the adult mouse. We anticipated that genetically induced acute depletion of APN in adult mice would have a more profound effect on systemic metabolic health than congenital deletion of Adipoq, the gene encoding APN, with its associated potential for adaptive responses that may mask the phenotypes.

Methods

Mice carrying loxP-flanked regions of Adipoq were generated and bred to the Adipoq (APN) promoter-driven reverse tetracycline-controlled transactivator (rtTA) (APN-rtTA) gene and a tet-responsive Cre line (TRE-Cre) to achieve acute depletion of APN. Upon acute removal of APN in adult mice, systemic glucose and lipid homeostasis were assessed under basal and insulinopenic conditions.

Results

The acute depletion of APN results in more severe systemic insulin resistance and hyperlipidaemia than in mice with congenital loss of APN. Furthermore, the acute depletion of APN in adult mice results in a much more dramatic reduction in survival rate, with 50% of inducible knockouts dying in the first 5 days under insulinopenic conditions compared with 0% of congenital Adipoq knockout mice under similar conditions.

Conclusions/interpretation

Acute systemic removal of APN results in a much more negative metabolic phenotype compared with congenital knockout of Adipoq. Specifically, our data demonstrate that acute depletion of APN is especially detrimental to lipid homeostasis, both under basal and insulinopenic conditions. This suggests that compensatory mechanisms exist in congenital knockout mice that offset some of the metabolic actions covered by APN.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Turer AT, Scherer PE (2012) Adiponectin: mechanistic insights and clinical implications. Diabetologia 55:2319–2326CrossRefPubMed Turer AT, Scherer PE (2012) Adiponectin: mechanistic insights and clinical implications. Diabetologia 55:2319–2326CrossRefPubMed
2.
Zurück zum Zitat Pischon T, Hotamisligil GS, Rimm EB (2003) Adiponectin: stability in plasma over 36 hours and within-person variation over 1 year. Clin Chem 49:650–652CrossRefPubMed Pischon T, Hotamisligil GS, Rimm EB (2003) Adiponectin: stability in plasma over 36 hours and within-person variation over 1 year. Clin Chem 49:650–652CrossRefPubMed
3.
Zurück zum Zitat Hotta K, Funahashi T, Bodkin NL et al (2001) Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 50:1126–1133CrossRefPubMed Hotta K, Funahashi T, Bodkin NL et al (2001) Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 50:1126–1133CrossRefPubMed
4.
Zurück zum Zitat Berg AH, Combs TP, Scherer PE (2002) ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 13:84–89CrossRefPubMed Berg AH, Combs TP, Scherer PE (2002) ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 13:84–89CrossRefPubMed
5.
Zurück zum Zitat Combs TP, Berg AH, Obici S, Scherer PE, Rossetti L (2001) Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J Clin Invest 108:1875–1881CrossRefPubMedPubMedCentral Combs TP, Berg AH, Obici S, Scherer PE, Rossetti L (2001) Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J Clin Invest 108:1875–1881CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Combs TP, Pajvani UB, Berg AH et al (2004) A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity. Endocrinology 145:367–383CrossRefPubMed Combs TP, Pajvani UB, Berg AH et al (2004) A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity. Endocrinology 145:367–383CrossRefPubMed
7.
Zurück zum Zitat Holland WL, Xia JY, Johnson JA et al (2017) Inducible overexpression of adiponectin receptors highlight the roles of adiponectin-induced ceramidase signaling in lipid and glucose homeostasis. Mol Metab 6:267–275CrossRefPubMedPubMedCentral Holland WL, Xia JY, Johnson JA et al (2017) Inducible overexpression of adiponectin receptors highlight the roles of adiponectin-induced ceramidase signaling in lipid and glucose homeostasis. Mol Metab 6:267–275CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Kubota N, Terauchi Y, Yamauchi T et al (2002) Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem 277:25863–25866CrossRefPubMed Kubota N, Terauchi Y, Yamauchi T et al (2002) Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem 277:25863–25866CrossRefPubMed
9.
Zurück zum Zitat Maeda N, Shimomura I, Kishida K et al (2002) Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 8:731–737CrossRefPubMed Maeda N, Shimomura I, Kishida K et al (2002) Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 8:731–737CrossRefPubMed
10.
Zurück zum Zitat Ma K, Cabrero A, Saha PK et al (2002) Increased beta-oxidation but no insulin resistance or glucose intolerance in mice lacking adiponectin. J Biol Chem 277:34658–34661CrossRefPubMed Ma K, Cabrero A, Saha PK et al (2002) Increased beta-oxidation but no insulin resistance or glucose intolerance in mice lacking adiponectin. J Biol Chem 277:34658–34661CrossRefPubMed
11.
Zurück zum Zitat Nawrocki AR, Rajala MW, Tomas E et al (2006) Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists. J Biol Chem 281:2654–2660CrossRefPubMed Nawrocki AR, Rajala MW, Tomas E et al (2006) Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists. J Biol Chem 281:2654–2660CrossRefPubMed
12.
Zurück zum Zitat Wang QA, Tao C, Gupta RK, Scherer PE (2013) Tracking adipogenesis during white adipose tissue development, expansion and regeneration. Nat Med 19:1338–1344CrossRefPubMedPubMedCentral Wang QA, Tao C, Gupta RK, Scherer PE (2013) Tracking adipogenesis during white adipose tissue development, expansion and regeneration. Nat Med 19:1338–1344CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Schraw T, Wang ZV, Halberg N, Hawkins M, Scherer PE (2008) Plasma adiponectin complexes have distinct biochemical characteristics. Endocrinology 149:2270–2282CrossRefPubMedPubMedCentral Schraw T, Wang ZV, Halberg N, Hawkins M, Scherer PE (2008) Plasma adiponectin complexes have distinct biochemical characteristics. Endocrinology 149:2270–2282CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Holland WL, Miller RA, Wang ZV et al (2011) Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nat Med 17:55–63CrossRefPubMed Holland WL, Miller RA, Wang ZV et al (2011) Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nat Med 17:55–63CrossRefPubMed
15.
Zurück zum Zitat Kusminski CM, Holland WL, Sun K et al (2012) MitoNEET-driven alterations in adipocyte mitochondrial activity reveal a crucial adaptive process that preserves insulin sensitivity in obesity. Nat Med 18:1539–1549CrossRefPubMedPubMedCentral Kusminski CM, Holland WL, Sun K et al (2012) MitoNEET-driven alterations in adipocyte mitochondrial activity reveal a crucial adaptive process that preserves insulin sensitivity in obesity. Nat Med 18:1539–1549CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the \( {2}^{-\Delta \Delta {\mathrm{C}}_{\mathrm{t}}} \) method. Methods 25:402–408CrossRefPubMed Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the \( {2}^{-\Delta \Delta {\mathrm{C}}_{\mathrm{t}}} \) method. Methods 25:402–408CrossRefPubMed
17.
18.
Zurück zum Zitat Xu Y, Wu Z, Sun H et al (2013) Glutamate mediates the function of melanocortin receptor 4 on Sim1 neurons in body weight regulation. Cell Metab 18:860–870CrossRefPubMed Xu Y, Wu Z, Sun H et al (2013) Glutamate mediates the function of melanocortin receptor 4 on Sim1 neurons in body weight regulation. Cell Metab 18:860–870CrossRefPubMed
19.
Zurück zum Zitat Razani B, Combs TP, Wang XB et al (2002) Caveolin-1-deficient mice are lean, resistant to diet-induced obesity, and show hypertriglyceridemia with adipocyte abnormalities. J Biol Chem 277:8635–8647CrossRefPubMed Razani B, Combs TP, Wang XB et al (2002) Caveolin-1-deficient mice are lean, resistant to diet-induced obesity, and show hypertriglyceridemia with adipocyte abnormalities. J Biol Chem 277:8635–8647CrossRefPubMed
20.
Zurück zum Zitat Holland WL, Adams AC, Brozinick JT et al (2013) An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice. Cell Metab 17:790–797CrossRefPubMedPubMedCentral Holland WL, Adams AC, Brozinick JT et al (2013) An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice. Cell Metab 17:790–797CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Davis KE, Scherer PE (2008) Adiponectin: no longer the lone soul in the fight against insulin resistance? Biochem J 416:e7–e9CrossRefPubMed Davis KE, Scherer PE (2008) Adiponectin: no longer the lone soul in the fight against insulin resistance? Biochem J 416:e7–e9CrossRefPubMed
23.
Zurück zum Zitat Bouret SG, Bates SH, Chen S, Myers MG Jr, Simerly RB (2012) Distinct roles for specific leptin receptor signals in the development of hypothalamic feeding circuits. J Neurosci 32:1244–1252CrossRefPubMedPubMedCentral Bouret SG, Bates SH, Chen S, Myers MG Jr, Simerly RB (2012) Distinct roles for specific leptin receptor signals in the development of hypothalamic feeding circuits. J Neurosci 32:1244–1252CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Bouret SG, Draper SJ, Simerly RB (2004) Trophic action of leptin on hypothalamic neurons that regulate feeding. Science 304:108–110CrossRefPubMed Bouret SG, Draper SJ, Simerly RB (2004) Trophic action of leptin on hypothalamic neurons that regulate feeding. Science 304:108–110CrossRefPubMed
25.
Zurück zum Zitat Xia JY, Holland WL, Kusminski CM et al (2015) Targeted induction of ceramide degradation leads to improved systemic metabolism and reduced hepatic steatosis. Cell Metab 22:266–278CrossRefPubMedPubMedCentral Xia JY, Holland WL, Kusminski CM et al (2015) Targeted induction of ceramide degradation leads to improved systemic metabolism and reduced hepatic steatosis. Cell Metab 22:266–278CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Holland WL, Brozinick JT, Wang LP et al (2007) Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metab 5:167–179CrossRefPubMed Holland WL, Brozinick JT, Wang LP et al (2007) Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metab 5:167–179CrossRefPubMed
27.
Zurück zum Zitat Turpin SM, Nicholls HT, Willmes DM et al (2014) Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance. Cell Metab 20:678–686CrossRefPubMed Turpin SM, Nicholls HT, Willmes DM et al (2014) Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance. Cell Metab 20:678–686CrossRefPubMed
28.
Zurück zum Zitat Holland WL, Scherer PE (2017) Structural biology: receptors grease the metabolic wheels. Nature 544:42–44CrossRefPubMed Holland WL, Scherer PE (2017) Structural biology: receptors grease the metabolic wheels. Nature 544:42–44CrossRefPubMed
29.
Zurück zum Zitat Vasiliauskaite-Brooks I, Sounier R, Rochaix P et al (2017) Structural insights into adiponectin receptors suggest ceramidase activity. Nature 544:120–123CrossRefPubMedPubMedCentral Vasiliauskaite-Brooks I, Sounier R, Rochaix P et al (2017) Structural insights into adiponectin receptors suggest ceramidase activity. Nature 544:120–123CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Lin Z, Tian H, Lam KS et al (2013) Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice. Cell Metab 17:779–789CrossRefPubMed Lin Z, Tian H, Lam KS et al (2013) Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice. Cell Metab 17:779–789CrossRefPubMed
31.
Zurück zum Zitat BonDurant LD, Ameka M, Naber MC et al (2017) FGF21 regulates metabolism through adipose-dependent and -independent mechanisms. Cell Metab 25:935-944.e4CrossRefPubMed BonDurant LD, Ameka M, Naber MC et al (2017) FGF21 regulates metabolism through adipose-dependent and -independent mechanisms. Cell Metab 25:935-944.e4CrossRefPubMed
Metadaten
Titel
Acute loss of adipose tissue-derived adiponectin triggers immediate metabolic deterioration in mice
verfasst von
Jonathan Y. Xia
Kai Sun
Chelsea Hepler
Alexandra L. Ghaben
Rana K. Gupta
Yu A. An
William L. Holland
Thomas S. Morley
Andrew C. Adams
Ruth Gordillo
Christine M. Kusminski
Philipp E. Scherer
Publikationsdatum
09.12.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Diabetologia / Ausgabe 4/2018
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-017-4516-8

Weitere Artikel der Ausgabe 4/2018

Diabetologia 4/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.